908 Devices (NASDAQ:MASS), founded in 2011 as a spin-off from Bruker Corporation, is a specialized analytical instrumentation company that designs and manufactures handheld and portable mass spectrometry solutions. Headquartered in Boston, Massachusetts, 908 Devices has positioned itself at the intersection of advanced science and field-ready application, pioneering compact systems that enable on-site chemical analysis across a range of industries.
The company’s flagship offerings include the M908 handheld mass spectrometer and the MX908 desktop GC-MS system. The M908 combines ambient ionization with a miniaturized mass analyzer to provide real-time detection and identification of illicit substances, chemical threats and trace contaminants. The MX908 integrates gas chromatography with high-performance mass spectrometry, delivering laboratory-grade analysis in a benchtop format tailored for forensic laboratories, pharmaceutical quality control and environmental testing facilities.
908 Devices serves a global customer base across North America, Europe, Asia-Pacific and the Middle East. Its solutions address critical needs in public safety, homeland security, food safety, environmental monitoring and pharmaceutical manufacturing. The company maintains regional sales and support teams to assist customers with device deployment, application development and ongoing technical service.
The executive leadership team at 908 Devices brings together seasoned professionals in analytical chemistry, engineering and commercial operations. Guided by a management group with extensive experience in life sciences instrumentation and defense technologies, the company continues to invest in research and development aimed at expanding its product portfolio, optimizing workflows and enhancing data analytics capabilities for users worldwide.
